Shire to offer €19 per share for Movetis

Tuesday 3 August 2010

Shire Plc has announced a tender offer for the recently-listed Belgian company, Movetis NV, which has a product for chronic constipation on markets in the European Union. Shire is offering €19 per share in cash for Movetis, representing a premium of 74% to Movetis’s closing price on NYSE Euronext Brussels on 2 August 2010.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Ireland